Literature DB >> 2915173

Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni.

S H Xiao1, B A Catto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2915173     DOI： 10.1093/infdis/159.3.589

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  17 in total

Review 1.  The redox biology of schistosome parasites and applications for drug development.

Authors:  Hsin-Hung Huang; Coraline Rigouin; David L Williams
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Time course of the effect of praziquantel on Schistosoma mansoni attachment in vitro: comparison with its effects on worm length and motility.

Authors:  S P da Silva; F Noël
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

3.  Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity.

Authors:  Renata Monteiro Lima; Maria Augusta Drago Ferreira; Teresa Maria de Jesus Ponte Carvalho; Bruno José Dumêt Fernandes; Osvaldo Massaiti Takayanagui; Hector Hugo Garcia; Eduardo Barbosa Coelho; Vera Lucia Lanchote
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

4.  Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel.

Authors:  Lalit Kumar Sharma; Pauline M Cupit; Tino Goronga; Thomas R Webb; Charles Cunningham
Journal:  Bioorg Med Chem Lett       Date:  2014-04-13       Impact factor: 2.823

5.  Metabolic profiling of praziquantel enantiomers.

Authors:  Haina Wang; Zhong-Ze Fang; Yang Zheng; Kun Zhou; Changyan Hu; Kristopher W Krausz; Dequn Sun; Jeffrey R Idle; Frank J Gonzalez
Journal:  Biochem Pharmacol       Date:  2014-05-10       Impact factor: 5.858

Review 6.  Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Amel el-Sahn; Azza Hassan
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

7.  Resolution of praziquantel.

Authors:  Michael Woelfle; Jean-Paul Seerden; Jesse de Gooijer; Kees Pouwer; Piero Olliaro; Matthew H Todd
Journal:  PLoS Negl Trop Dis       Date:  2011-09-20

8.  Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni.

Authors:  Isabel Meister; Katrin Ingram-Sieber; Noemi Cowan; Matthew Todd; Murray N Robertson; Claudia Meli; Malay Patra; Gilles Gasser; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

9.  Cocrystals of Praziquantel: Discovery by Network-Based Link Prediction.

Authors:  Jan-Joris Devogelaer; Maxime D Charpentier; Arnoud Tijink; Valérie Dupray; Gérard Coquerel; Karen Johnston; Hugo Meekes; Paul Tinnemans; Elias Vlieg; Joop H Ter Horst; René de Gelder
Journal:  Cryst Growth Des       Date:  2021-05-20       Impact factor: 4.076

10.  Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment.

Authors:  Thorsten Meyer; Harald Sekljic; Stefan Fuchs; Heiko Bothe; Dieter Schollmeyer; Christian Miculka
Journal:  PLoS Negl Trop Dis       Date:  2009-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.